<DOC>
	<DOCNO>NCT02294149</DOCNO>
	<brief_summary>The purpose study determine whether administration mammalian Omega 3 FA ( fatty acid ) Vitamin D3 supplement would lower prevent risk neuropathy due chemotherapy .</brief_summary>
	<brief_title>Vit D3 Omega 3 Chemo Induced Neuropathy</brief_title>
	<detailed_description>The primary objective study evaluate impact mammalian oil Omega 3 FA Vitamin D3 supplementation resolution prevention Taxanes Platinum induce peripheral neuropathy compare placebo . Patients allocate receive Omega 3 FA &amp; Vitamin D3 supplement placebo 6 month . Approximately 600 patient total enrol 2 study arm . The evaluation neuropathy accomplish electromyography ( EMG ) , Total neuropathy score ( TNS ) , Brief pain inventory ( BFI ) 11-item FACT/GOG-Ntx , version 4 questionnaire ( subscale validate ass neuropathy due chemotherapy ) . In addition , validate functional measure `` Time button six hole shirt '' `` 50 ft walk speed test '' use test patient physical limitation impose peripheral neuropathy . All patient undergo EMG first visit , 3 month 6months . Previously mention functional measure also complete patient ' first visit , 3 month 6 month .</detailed_description>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Will receive chemotherapy ( Platinums and/or Taxanes ) follow 2 week . Histologically confirm diagnosis cancer ECOG 0 2 Prior chemotherapy treatment Preexisting peripheral PN due DM , HIV , alcohol abuse , thyroid dysfunction hereditary PN associate disorder . Taking nutritional supplement ( fish oil , vitamins mineral ) least month enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>chemotherapy</keyword>
	<keyword>Omega 3</keyword>
</DOC>